Weight Loss Doctor in New Brunswick, New Jersey

GLP-1 (glucagon-like peptide 1) is a hormone that stimulates glucose-dependent insulin production and has a significant impact on blood sugar management. Insulin is a hormone that encourages the uptake of sugar by cells, stores sugar as glycogen, stimulates fat storage, and instructs the body to create skeletal muscle. GLP-1 also suppresses glucagon release (which delays the release of sugar into the bloodstream, causing you to burn more fat), slows stomach emptying (which makes you feel full), and reduces the desire to eat (because you feel full).

GLP-1 Agonist is not an insulin replacement or a form of insulin. When glucose (sugar) is present, GLP-1 Agonist stimulates your pancreas to release insulin. GLP-1 Agonist isn’t utilized when your pancreas can’t create insulin, such as in type 1 diabetes patients, because it relies on your body’s own insulin to have this effect.

GLP-1 Agonist isn’t a stimulant at all. GLP-1 Agonist works differently than other weight reduction drugs like phentermine, which have stimulating effects that help you lose weight (see above).

  GLP-1 agonists help you lose weight while also helping you control your blood sugar. The main hormone involved is GLP-1, which slows down the rate at which food is discharged from your stomach (called gastric emptying). In addition to allowing your pancreas to release insulin, the GLP-1 agonist suppresses a hormone that stimulates your liver to release sugar (glucagon). When these processes work together, you’ll feel less hungry, which will allow you to eat less and lose more weight.

Yes, it is thought that GLP-1 Agonist can help you lose weight. GLP-1 plays a direct influence in how your appetite is regulated, in addition to slowing gastric emptying to make you feel fuller for longer.

With GLP-1 Agonist, you’ll gradually increase to the target dose, at which point you’ll notice the biggest weight loss. This was the situation in the clinical studies, where participants’ doses were gradually increased until they reached a weekly dose of 2.4 mg. Most participants were able to attain the full dose in the phase 3 trial, which examined outcomes at 20 weeks, and they also lost weight as their dose was increased. At the full dose, they lost even more weight over the next 48 weeks. It’s crucial to remember that weight loss takes time, and the best benefits come from combining your medicine with a good diet and regular exercise. Sometimes the medication may not work for you, or you may not be able to tolerate the full dose due to side effects.

GLP-1 Agonist is currently licensed by the FDA solely to help with blood sugar control in patients with type 2 diabetes and to reduce the risk of significant cardiovascular events (such as heart attack and stroke) in people who have both type 2 diabetes and heart disease. If you’re using GLP-1 Agonist for either of these reasons, you’ll follow your healthcare provider’s instructions because you’re managing a chronic ailment. If you don’t have type 2 diabetes and want to test GLP-1 Agonist to help you lose weight, we’ll know more about long-term safety once the FDA examines the evidence for this new indication. What we do know is that study participants received treatment for a period of 68 weeks (about 1.5 years) during each of the four trials conducted by the company.

Yes. When taken as directed, GLP-1 Agonist is deemed safe and effective. However, just because something is safe does not mean it is without risk. GLP-1 Agonist also comes with a boxed warning about thyroid C-cell tumors in rats (with uncertain risk in humans), and it shouldn’t be used if you or someone in your family has had thyroid cancer. People with type 1 diabetes with a history of pancreatitis should avoid taking GLP-1 Agonist. People who are using other blood sugar-lowering drugs should use GLP-1 Agonist with caution.

The amount being investigated for weight reduction is 2.4 mg once weekly, which is higher than the levels currently approved for diabetes. Furthermore, GLP-1 Agonist is being investigated in a separate group of people: those with a BMI of greater than or equal to 30 kg/m2 alone or 27 kg/m2 with at least one weight-related comorbidities (diabetes excluded).

No. For persons who do not have type 2 diabetes, GLP-1 Agonist is not covered by insurance. However, as part of our GLP-1 Agonist Weight Loss Program, you may be able to obtain this drug.

Every week, all patients are given the GLP-1 Agonist – injected subcutaneously into belly fat. All patients get a weekly dose increase depending on patient comfort and weight loss goals. 

If you’re using a GLP-1 Agonist, there are a few things to keep in mind.

To begin, you should minimize your alcohol consumption while taking GLP-1 Agonist, especially if you have diabetes. Alcohol has an effect on your blood sugar, and when combined with GLP-1 Agonist, there’s a chance it’ll drop too low, especially if you’re drinking on an empty stomach. It’s also possible that alcohol will irritate your stomach. When combined with any of the medication’s GI adverse effects, this could make you feel much worse.

If you’re taking any oral drugs, you’ll want to be cautious. Because GLP-1 Agonist reduces stomach emptying, it may have an impact on how much oral medication your body absorbs. And while trials haven’t shown this to be significant with GLP-1 Agonist, you’ll want to make sure your provider is aware of any other medications you are taking before starting GLP-1 Agonist.

The following are some of the most prevalent GLP-1 Agonist adverse effects:

• Nausea
• Vomiting
• Diarrhea
• Stomach pain
• Constipation

Rarely, but it can happen. GLP-1 Agonists have the potential to induce major adverse effects, including as:

• Vomiting for a long time Patients taking GLP-1 Agonist may develop gastroparesis, a condition in which the stomach stops moving and the patient vomits a lot. Dehydration and electrolyte abnormalities can result as a result of this. If you have vomiting that lasts more than a day, stop taking GLP-1 Agonist and contact your doctor right once.
• Your pancreas is inflamed (pancreatitis). If you get severe stomach pain (abdomen) that won’t go away, with or without vomiting, stop taking GLP-1 Agonist and contact your doctor right once. The pain may radiate from your abdomen to your back.
• Visional shifts. If you notice changes in your vision while taking GLP-1 Agonist, tell your doctor.
• Blood sugar levels are low (hypoglycemia). If you use GLP-1 Agonist with another prescription that might cause low blood sugar, such as a sulfonylurea or insulin, your chances of experiencing low blood sugar are increased. Dizziness or lightheadedness, blurred vision, anxiety, irritability, or mood changes, sweating, slurred speech, hunger, disorientation or drowsiness, shakiness, weakness, headache, fast heartbeat, and feeling jittery are all signs and symptoms of low blood sugar.
• Problems with the kidneys (kidney failure). Diarrhea, nausea, and vomiting in persons with renal difficulties can lead to a loss of fluids (dehydration), which can exacerbate kidney problems. It’s critical that you drink plenty of water to avoid becoming dehydrated.
• Allergic reactions that are severe. If you have any symptoms of a significant allergic reaction, such as swelling of your face, lips, tongue, or throat; difficulty breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or a very rapid heartbeat, stop using GLP-1 Agonist and get medical attention right once.